Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management.
The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia.
Measurement and maintenance of reserve in multiple sclerosis.
Botulinum toxin type A injection for neurogenic detrusor overactivity: Clinical outcome in Japanese patients.
Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.
Laquinimod therapy in multiple sclerosis: a comprehensive review.
Randomized controlled pilot study of customized pamphlets to promote physical activity and symptom self-management in women with multiple sclerosis.
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
Short-term effect of aerobic exercise on symptoms in multiple sclerosis and chronic fatigue syndrome: a pilot study.
SOX2+ Cell Population from Normal Human Brain White Matter Is Able to Generate Mature Oligodendrocytes.
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.
The disruption of mitochondrial axonal transport is an early event in neuroinflammation.
Vestibular and ocular motor function prior to and after therapeutic apheresis with small plasmafilter in multiple sclerosis.
Body mass index during adolescence, rather than childhood, is critical in determining MS risk.
Magnetic susceptibility and isothermal remanent magnetization in human tissues: a study case.
New discovery rarely runs smooth: an update on progranulin/TNFR interactions.
Prostacyclin Prevents Pericyte Loss and Demyelination Induced by Lysophosphatidylcholine in the Central Nervous System.
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Temporal filtering of longitudinal brain magnetic resonance images for consistent segmentation.
Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation.
Progressive multifocal leukoencephalopathy in an immunocompetent patient.
Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study.
Pages
« first
‹ previous
…
673
674
675
676
677
678
679
680
681
…
next ›
last »